ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
126.139,20
0,72%
S&P 500
6.049,88
0,05%
US Dollar vs BRL
6,0444
0,00%
Bitcoin
96.185,43
0,22%
Brent Oil
73,735
0,18%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. International Stem Cell Corporation (QB) (ISCO)

  7. International Stem Cell Corporation (QB) (ISCO) Notícias

ISCO

International Stem Cell (QB) (ISCO)

International Stem Cell Corporation (QB)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:ISCO
DataHoraFonteTítuloCódigoCompanhia
13/11/202418:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ISCOInternational Stem Cell Corporation (QB)
13/06/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ISCOInternational Stem Cell Corporation (QB)
27/09/202313:27Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:ISCOInternational Stem Cell Corporation (QB)
18/09/202309:01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ISCOInternational Stem Cell Corporation (QB)
21/06/202315:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
16/06/202318:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
12/05/202317:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
28/04/202317:31Edgar (US Regulatory)Annual Report to Security Holders (ars)USOTC:ISCOInternational Stem Cell Corporation (QB)
30/03/202317:37Edgar (US Regulatory)Annual Report (10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
27/04/202217:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ISCOInternational Stem Cell Corporation (QB)
26/06/202019:07Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
13/05/202014:35Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
14/08/201918:07Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
29/04/201909:30InvestorsHub NewsWireInternational Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
16/04/201909:30InvestorsHub NewsWireInternational Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End ResultsUSOTC:ISCOInternational Stem Cell Corporation (QB)
07/03/201908:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
13/02/201911:30InvestorsHub NewsWireInternational Stem Cell Corporation Publishes Successful Results in Traumatic Brain InjuryUSOTC:ISCOInternational Stem Cell Corporation (QB)
15/01/201911:30InvestorsHub NewsWireInternational Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging BusinessUSOTC:ISCOInternational Stem Cell Corporation (QB)
05/12/201811:30InvestorsHub NewsWireInternational Stem Cell Corporation is Valued at $6.16 per Share by Edison Investment ResearchUSOTC:ISCOInternational Stem Cell Corporation (QB)
15/11/201811:30InvestorsHub NewsWireInternational Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018USOTC:ISCOInternational Stem Cell Corporation (QB)
05/11/201811:30InvestorsHub NewsWireInternational Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
30/10/201809:30InvestorsHub NewsWireInternational Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual MeetingUSOTC:ISCOInternational Stem Cell Corporation (QB)
08/10/201809:30InvestorsHub NewsWireInternational Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
02/10/201809:00InvestorsHub NewsWireInternational Stem Cell Corporation Raised Funds Through a Private Placement at Premium to MarketUSOTC:ISCOInternational Stem Cell Corporation (QB)
21/08/201808:00InvestorsHub NewsWireInternational Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic ProgramUSOTC:ISCOInternational Stem Cell Corporation (QB)
15/08/201808:00InvestorsHub NewsWireInternational Stem Cell Corp Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018USOTC:ISCOInternational Stem Cell Corporation (QB)
15/08/201807:49Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ISCOInternational Stem Cell Corporation (QB)
10/07/201808:00InvestorsHub NewsWireInternational Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical ProductsUSOTC:ISCOInternational Stem Cell Corporation (QB)
11/06/201808:00InvestorsHub NewsWireInternational Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
05/06/201808:00InvestorsHub NewsWireInternational Stem Cell Corporation to Launch Advanced Joint SupplementUSOTC:ISCOInternational Stem Cell Corporation (QB)
 Apresentando as notícias mais relevantes sobre:USOTC:ISCO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BOBR4
BOMBRIL PN
BOV
IFCM3
Infracommerce Caxaas ON
BOV
GFSA3
GAFISA ON
BOV
ATOM3
ATOMPAR ON
BOV
AZEV4
AZEVEDO PN
BOV
OIBR3
OI ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados